FRIDAY, March 17, 2023 (HealthDay News) – Sanofi Inc. on Thursday became the third company to announce it will slash prices on its insulin products. The French company announced that it will cut prices by 78% and cap out-of-pocket charges for its insulin, brand named Lantus, at $35 per month.Continue Reading
TUESDAY, March 14, 2023 (HealthDay News) — Novo Nordisk Inc. on Tuesday became the third drug company to say it will slash prices on some of its insulin products. Starting in January 2024, there will be a 75% price cut for NovoLog and NovoLog Mix 70/30, while Novolin and LevemirContinue Reading
WEDNESDAY, March 1, 2023 (HealthDay News) — More Americans will soon be paying less for their insulin. Eli Lilly, one of the three insulin manufacturers, plans to cut its list prices of the drug by 70% and cap out-of-pocket costs at $35 a month. “While the current health care systemContinue Reading
TUESDAY, Feb. 7, 2023 (HealthDay News) — If you are one of the millions of people distressed by low libido, help may be on the way in the form of a new hormone shot. Two new British studies suggest that injections of the hormone kisspeptin could boost sexual desire inContinue Reading
FRIDAY, Feb. 3, 2023 (HealthDay News) — People with health conditions like type 2 diabetes, gestational diabetes or polycystic ovarian syndrome may have been advised about the value of an insulin-resistance diet. But this way of eating can benefit most people interested in balancing blood sugars, whether that’s to helpContinue Reading
TUESDAY, Jan. 31, 2023 (HealthDay News) — The “love hormone” oxytocin might not play the critical role in forming social bonds that scientists have long believed, a new animal study suggests. Prairie voles bred without receptors for oxytocin display the same monogamous mating, attachment and parenting behaviors as regular voles,Continue Reading
THURSDAY, Jan. 19, 2023 (HealthDay News) — As numerous U.S. states move to restrict transgender health care, a new study shows that such care can substantially improve teenagers’ mental health. The study, published in the New England Journal of Medicine, followed transgender and nonbinary teenagers who received “gender-affirming” hormones —Continue Reading
FRIDAY, Jan. 13, 2023 (HealthDay News) — An artificial pancreas has long been considered the holy grail for people with type 1 diabetes, and new research suggests a more convenient version of this technology may help the millions of people living with type 2 diabetes. Type 2 is the moreContinue Reading
TUESDAY, Dec. 13, 2022 (HealthDay News) — Insulin pumps can help folks with type 1 diabetes get better control of their disease and minimize how often they inject insulin, and use of the devices has taken off in the past 20 years. That’s the good news from a new study.Continue Reading
WEDNESDAY, Nov. 16, 2022 (HealthDay News) — California’s plan to manufacture its own insulin could be a huge money-saver for state residents with diabetes — and possibly be a model for other states, according to experts. Earlier this year, California announced an initiative to bring its own insulin products toContinue Reading